Related Experiment Video

Updated: Jul 9, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Biological therapy of breast cancer: recent clinical applications

Joseph Baar1

  • 1Case Western Reserve University, Ireland Cancer Center, 11100 Euclid Avenue, Cleveland, OH 44011, USA. joseph.baar@uhhospitals.org

Current Opinion in Investigational Drugs (London, England : 2000)
|December 7, 2007
PubMed

Insights

Recent breast cancer research advances include identifying women who may avoid chemotherapy and developing targeted therapies. New research explores breast cancer stem cells and micrometastases for improved treatment strategies.

Area of Science:

  • Oncology
  • Genomics
  • Pharmacology

Background:

  • Breast cancer treatment has advanced in both early (adjuvant) and advanced (metastatic) stages.
  • Genomic studies are refining treatment decisions for estrogen receptor-positive tumors.
  • Targeted therapies against HER2/neu, angiogenesis, and kinase pathways show significant progress.

Purpose of the Study:

  • To review recent clinical research advances in breast cancer therapy.
  • To highlight developments in diagnostic tools and targeted anticancer agents.
  • To discuss emerging research areas like cancer stem cells and micrometastases.

Main Methods:

  • Review of recent clinical research findings.
  • Analysis of genomic studies for treatment stratification.
  • Evaluation of targeted therapies and novel research concepts.

Main Results:

  • Identification of patients with estrogen receptor-positive tumors who may not need chemotherapy.
  • Development of diagnostic tools based on genomic profiling.
  • Progress in targeted therapies including anti-HER2/neu agents, anti-angiogenesis drugs, and kinase inhibitors.

Conclusions:

  • Significant therapeutic advances have been achieved in breast cancer management.
  • Genomic insights are personalizing adjuvant chemotherapy decisions.
  • Emerging research on breast cancer stem cells and micrometastases holds prognostic and therapeutic potential.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...